Home Life Sciences MiR-107 inhibits proliferation of lung cancer cells through regulating TP53 regulated inhibitor of apoptosis 1 (TRIAP1)
Article Open Access

MiR-107 inhibits proliferation of lung cancer cells through regulating TP53 regulated inhibitor of apoptosis 1 (TRIAP1)

  • Bing Wang , Zhanjie Zuo , Fang Lv , Liang Zhao , Minjun Du and Yushun Gao EMAIL logo
Published/Copyright: July 6, 2017

Abstract

Aims

Accumulating evidence indicates that aberrant expression of miR-107 plays a crucial role in cancers. This study aims to display the function of miR-107 and its novel target genes in the progression of lung cancer.

Methods and Material

MiR-107 or miR-107 inhibitor was transfected into lung cancer cells A549. The levels of miR-107 and TP53 regulated inhibition of apoptosis 1 (TRIAP1) were examined by quantitative real-time Polymerase Chain Reaction (qRT-PCR) analysis and Western Blot. Functionally, MTT and colony formation assays were carried out to test the effect of miR-107 inhibitor and/or small interference RNA (siRNA) targeting TRIAP1 mRNA on proliferation of lung cancer cells. Levels of miR-107 or TRIAP1 were detected in clinical lung cancer samples by using qRT-PCR analysis.

Results

QRT-PCR analysis revealed that miR-107 inhibitor or miR-107 was successfully transfected into A549 cells. Western Blot indicated that miR-107 decreased the expression of TRIAP1 protein in the cells. In contrast, miR-107 inhibitor augmented the levels of TRIAP1 protein. Functionally, miR-107 inhibitor remarkably suppressed A549 cell proliferation, whereas, TRIAP1 siRNAs could abrogate the miR-107 inhibitor-induced proliferation of cells. Then, we validated that TRIAP1 was increased in clinical lung cancer samples. MiR-107 expression was negatively related to TRIAP1 expression in clinical lung cancer samples.

Conclusions

MiR-107 suppresses cell proliferation by targeting TRIAP1 in lung cancer. Our finding allows new insights into the mechanisms of lung cancer that is mediated by miR-107.

1 Introduction

Lung cancer is the principle cause of global cancer-associated mortality accounting for about 1.59 million deaths every year worldwide [1, 2]. Most of those cases have non-small-cell lung cancer (NSCLC) [3].

MicroRNAs (miRNAs) usually negatively modulate gene expression through mRNA cleavage or translational repression [4]. Normally, conserved miRNAs plays a part in many processes, such as cell proliferation, apoptosis, and metabolism. Numerous miRNAs play important roles in cancers as oncogenes or tumour suppressor genes [5-10]. MiR-107 is proven to be involved in many cancers, such as colon, breast, gastric, liver, and bladder [11-17]. It has been reported that miR-107 results in cell cycle arrest to suppress cell proliferation in lung adenocarcinoma [18]. Lowly-expressed miR-107 correlates with tumor development and patient survival in NSCLC [19]. However, it remains unclear how miR-107 works in lung cancer.

In the current study, we explored the effect of miR-107 and its novel target gene on proliferation of lung cancer cells. Our findings indicate that TRIAP1 serves as a novel target gene of miR-107 in lung cancer A549 cells. MiR-107 restrains the proliferation of lung cancer cells through regulating TRIAP1. Our finding takes a further step into the mechanism of miR-107-associated lung cancer.

2 Materials and Methods

2.1 Cell culture

A549 cells (a lung cancer cell line), were grown in Dulbecco’s modified Eagle’s medium with 10% fetal bovine serum (Gibco, USA), 100U/mL penicillin and 100U/ mL streptomycin. The container works in 5% CO2 at 37°C.

2.2 MiRNA and siRNA transfection

Cells were seeded into 6-well or 96-well plates 24h before transfection. Lipofectamine 2000 (Invitrogen, USA) was used to transfect miRNAs and siRNAs into cells. MiR-107 (5′-AGCAGCAUUGUACAGGGCUAUCA-3′), miR-107 inhibitor (5′-UGAUAGCCCUGUACAAUGCUGCU-3′), miRNA control (Ctrl: 5′-UUCUUCGAAGGUGUGACGU-3′), siRNA control (siCtrl: 5′-AAUGGUCAUGGUCUUAUUCC-3′) or siTRIAP1 (5′-AGGCAUGCACGGACAUGAATT-3′) were synthesized by GenePharma (Shanghai, China).

2.3 Quantitative real-time polymerase chain reaction (qRT-PCR)

Trizol (Invitrogen, USA) was utilized to extract total RNA of cells/patient samples as described previously [15]. We polyadenylated total RNA through poly (A) polymerase (Thermo Fisher Scientific, USA). Reverse Transcriptase came from TransGen Biotech (Beijing, China). The qRT-PCR was applied by TransStart Top Green qPCR SuperMix (TransGen Biotech, China). The primers used were listed: U6 sense, 5′-CTCGCTTCGGCAGCACA-3′, antisense, 5′-AACTCTTCACTAATTTGCTG-3′; GAPDH sense, 5′- AACGGATTTGGTCGTATTG-3′, antisense, 5′-GGAAGATGGTGATGGGATT-3′; miR-107 sense, 5′-AGCAGCATTGTACAGGGCTATCA-3′, antisense, 5′-GCGAGCACAGAATTAATACGAC-3′; TRIAP1 sense, 5′- TATCTTGCAGGAACTGTGTGCTA-3′, antisense, 5′- AATTTAGGTTCTTCCTCCACAGC-3′.

2.4 Western blot

48 hours after transfection, cell lysis was prepared at 4°C using RIPA buffer (Biomed, China). Proteins were transferred to membranes from the electrophoresis gel and then were blocked for 2 h in 5% non-fat dried milk powder in 0.1% PBST. The membranes were detected with anti-TRIAP1 antibody (Santa Cruz Biotechnology, USA). Anti-β-actin (Sigma, USA) served as a protein loading control. Detection was visualized by ECL Western Blotting Substrate (Solarbio, Beijing, China). The experiments were repeated three times at least.

2.5 Cell growth measurement

For quantitative proliferation assays, one thousand A549 cells were seeded into 96-well plates for 12h. Methylthiazolyl tetrazolium (MTT) (Sigma, USA) assays were performed to evaluate cell proliferation. The absorbance value (OD) at 490 nm of each well was measured every 24h from 24h to 72h after transfection.

2.6 Colony formation assay

Forty-eight hours post-transfection, one thousand cells were plated in six-well plates. The cells have been grown in complete medium for 2 weeks until the colonies were visible. The colonies werestained with methylene blue. The experiments were repeated in triplicate.

2.7 Patient samples

Clinical lung tumor samples and corresponding peritumor samples (25 cases) were attained from Cancer Hospital Chinese Academy of Medical Sciences (Beijing, China) after surgical resection. The patients approved the use of their tissues for study. The information of the patients was listed in Table 1.

Table 1

Clinical characteristics of lung cancer samples

No.SexAgePathology diagnosis
1F42lung adenocarcinoma
2M39lung adenocarcinoma
3F53lung adenocarcinoma
4M57lung squamous carcinoma
5M62lung squamous carcinoma
6F59lung squamous carcinoma
7M46lung squamous carcinoma
8M57lung squamous carcinoma
9F61lung squamous carcinoma
10M64lung squamous carcinoma
11F48lung adenocarcinoma
12M47lung squamous carcinoma
13F52lung adenocarcinoma
14M57lung adenocarcinoma
15M40lung squamous carcinoma
16M53lung adenocarcinoma
17M68lung squamous carcinoma
18M59lung adenocarcinoma
19M50lung adenocarcinoma
20F46lung adenocarcinoma
21F42lung adenocarcinoma
22M55lung adenocarcinoma
23M46lung adenocarcinoma
24M69lung adenocarcinoma
25M59lung squamous carcinoma

Informed consent: Informed consent has been obtained from all individuals included in this study.

Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the Research Ethics Committee at Cancer Hospital Chinese Academy of Medical Sciences.

2.8 Statistical analysis

The experiment was performed in triplicate. Statistical analysis was thought as significant by comparing mean values (±standard deviation, SD) using a Student’s t test (*P < 0.05, **P < 0.01). The correlation between miR-107 and TRIAP1 in clinical lung cancer tissues was analysed using a Pearson’s correlation coefficient.

3 Results

3.1 MiR-107 depresses TRIAP1 expression in lung cancer cells

To elucidate the function of miR-107 in lung cancer, we predicted the target genes of miR-107 using Targetscan software (http://www.targetscan.org/). We found that oncogene TRIAP1, was a potential target gene of miR-107. To evaluate the effect of miR-107 on TRIAP1, miR-107 was transiently transfected into lung cancer A549 cells. Ectopic miR-107 expression decreased levels of TRIAP1 protein in A549 cells (Figure. 1A). Whereas, TRIAP1 was elevated when cellular miR-107 was inhibited by miR-107 inhibitor (Figure. 1B), implying that miR-107 can restrain TRIAP1 expression in cells. Overexpressed miR-107 or miR-107 inhibitor was confirmed by qRT-PCR assay (Figure. 1A and 1B). Overall, we find that miR-107 can inhibit TRIAP1 in lung cancer cells.

Figure 1 MiR-107 decreases TRIAP1 expression in lung cancer cells. (A) TRIAP1 level was analyzed In A549 cells with miR-107 treatment by using Western Blot analyses. A QRT-PCR assay was utilized to confirm miR-107 transfection. (B) TRIAP1 expression was tested in A549 cells with miR-107 inhibitor (anti-miR-107) through Western Blot analyses. QRT-PCR assay was utilized to confirm miR-107 inhibitor transfection. (*P < 0.05, **P < 0.01; Student’s t test)
Figure 1

MiR-107 decreases TRIAP1 expression in lung cancer cells. (A) TRIAP1 level was analyzed In A549 cells with miR-107 treatment by using Western Blot analyses. A QRT-PCR assay was utilized to confirm miR-107 transfection. (B) TRIAP1 expression was tested in A549 cells with miR-107 inhibitor (anti-miR-107) through Western Blot analyses. QRT-PCR assay was utilized to confirm miR-107 inhibitor transfection. (*P < 0.05, **P < 0.01; Student’s t test)

3.2 MiR-107 depresses lung cancer cell proliferation through TRIAP1

Based on that miR-107 could regulate oncogene TRIAP1, we further probed into the role of miR-107 targeting TRIAP1 in the development of lung cancer. We carried out MTT and colony formation assays in lung cancer A549 cells treated with miR-107 inhibitor. Our data demonstrated that A549 cell proliferation was increased after the cells were treated with miR-107 inhibitor, and then TRIAP1 silencing could abrogate miR-107 inhibitor-enhanced proliferation (Figure. 2A and 2B). We indicate that miR-107 inhibits cell proliferation by modulating TRIAP1 in lung cancer.

Figure 2 MiR-107 restrains lung cancer cell proliferation via TRIAP1. (A, B) Cell proliferation of A549 cells by anti-miR-107 (or anti-miR-107/ siTRIAPl) was evaluated by MTT and colony formation assays. (**P < 0.01; Student’s t test)
Figure 2

MiR-107 restrains lung cancer cell proliferation via TRIAP1. (A, B) Cell proliferation of A549 cells by anti-miR-107 (or anti-miR-107/ siTRIAPl) was evaluated by MTT and colony formation assays. (**P < 0.01; Student’s t test)

3.3 MiR-107 negatively correlates with TRIAP1 in clinical lung cancer patient samples

To validate the connection of miR-107 with TRIAP1 in clinical samples, we tested the TRIAP1 expression in 25 samples of human lung tumor tissues and peritumor tissues through qRT-PCR. Our data showed that TRIAP1 was very highly expressed in all the 25 lung tumor tissues when compared with their peritumor counterparts (Figure. 3A). Moreover, we observed a negative correlation between miR-107 and TRIAP1 (P < 0.05, Pearson’s correlation coefficient, r=-0.7326) (Figure. 3B). Thus, we prove that miR-107 is negatively related to TRIAP1 in lung cancer tissues.

Figure 3 MiR-107 is negatively related to TRIAP1 in clinical lung cancer samples. (A) TRIAP1 expression was investigated by qRT-PCR assay in 25 lung tumor samples and peritumor samples. (B) QRT-PCR analysis was applied to determine correlation of miR-107 with TRIAP1 in above tumor samples (Pearson’s correlation coefficient, r=-0.7326). (*P < 0.05, **P < 0.01; Student’s t test)
Figure 3

MiR-107 is negatively related to TRIAP1 in clinical lung cancer samples. (A) TRIAP1 expression was investigated by qRT-PCR assay in 25 lung tumor samples and peritumor samples. (B) QRT-PCR analysis was applied to determine correlation of miR-107 with TRIAP1 in above tumor samples (Pearson’s correlation coefficient, r=-0.7326). (*P < 0.05, **P < 0.01; Student’s t test)

4 Discussion

Lung cancer remains the main cause of cancer-related mortality worldwide. Most cases are usually classified as non-small-cell lung cancer. Commonly, activated EGFR mutations are used as predictive biomarkers [20]. MiRNA networks are reported to be associated with cancers through various mechanisms. Evidence suggests that miR-107 is involved in many cancers [11-17].

In the present study, we discuss new target genes and the function of miR-107 in lung cancer. We observe that miR-107 could inhibit TRIAP1 expression in lung cancer cells. Our results suggest that TRIAP1 is a novel target gene of miR-107. Importantly, miR-107 inhibitor significantly promotes the proliferation of lung cancer cells in vitro. Conversely, knockdown of TRIAP1 could abrogate the miR-107 inhibitor-enhanced proliferation of lung cancer cells. Clinically, TRIAP1 was remarkably augmented in clinical lung cancer tissues. Finally, we showed a significantly negative correlation of miR-107 with TRIAP1 in lung cancer tissues.

Different expression pattern of miR-107 is found in some signal pathways, such as cell cycle arrest, angiogenesis and hypoxia. A report has shown that miR-107 is closely related to survival in patients with NSCLC [19]. MiR-107 targeting cyclin dependent kinase 8 (CDK8) is involved in cisplatin chemosensitivity of NSCLC A549 cells [21]. Previous evidence indicates that lncRNA H19 activated by c-Myc can down-regulate miR-107 to promote cell cycle progression of NSCLC [22]. Recent findings suggest that miR-107 can suppress NSCLC metastasis by targeting BDNF [23]. Our findings further confirm these reports in which miR-107 serves as a tumor suppressor gene in cancers. Notably, we provide the first evidence that miR-107 targeting TRIAP1 participate in the lung cancer progression.

TRIAP1, also known as P53CSV, is firstly characterized as a p53-inducible gene and can inhibit apoptosis by interacting with the Hsp70/Apaf-1 complex [24]. Some genes including TRIAP1 are reported to be up-regulated and play a crucial role in multiple myeloma [25, 26]. A genome-wide genetic screen in human cells indicates that TRIAP1 is a specific repressor of p21, one p53 target gene [27]. Evidence reveals that TRIAP1 is also involved in prostate cancer bone metastasis [28]. A report describes that TRIAP1 is up-regulated in drug-resistant breast cancer cells and altered expression of TRIAP1 changes cellular sensitivity to doxorubicin in breast cancer [29]. MiR-320b-inhibited TRIAP1 is involved in progression in nasopharyngeal carcinoma [30]. Our data take a further step to the function of TRIAP1 in lung cancer.

Taken together, we present a novel target gene of miR-107 in controlling proliferation of lung cancer cells. MiR-107 is capable of down-regulating TRIAP1 which suppresses cell proliferation in lung cancer. We validate the negative correlation of miR-107 and TRIAP1 in clinical lung cancer tissues. Thus, our finding takes a further step into the mechanism of the development of lung cancer mediated by miR-107. Therapeutically, the miR-107 or TRIAP1 genes may be potential targets for lung cancer treatments.

  1. Conflicts of interest: Authors state no conflict of interest.

References

[1] Torre L.A., Bray F., Siegel R.L., Ferlay J., Lortet-Tieulent J., Jemal A., et al., Global cancer statistics, 2012. CA Cancer J Clin., 2015, 65(2), 87-108.10.3322/caac.21262Search in Google Scholar PubMed

[2] Torre L.A., Siegel R.L., Jemal A., Lung Cancer Statistics. Adv Exp Med Biol., 2016, 893, 1-19.10.1007/978-3-319-24223-1_1Search in Google Scholar PubMed

[3] Siegel R., Ma J., Zou Z., Jemal A., Cancer statistics, 2014., CA Cancer J Clin., 2014, 64(1), 9-29.10.3322/caac.21208Search in Google Scholar PubMed

[4] Bartel DP., MicroRNAs: target recognition and regulatory functions, Cell., 2009, 136(2), 215-233.10.1016/j.cell.2009.01.002Search in Google Scholar PubMed PubMed Central

[5] Han H., Sun D., Li W., Shen H., Zhu Y., Li C., et al., A c-Myc-MicroRNA functional feedback loop affects hepatocarcinogenesis, Hepatology., 2013, 57(6), 2378-2389.10.1002/hep.26302Search in Google Scholar PubMed

[6] Maurel M., Jalvy S., Ladeiro Y., Combe C., Vachet L., Sagliocco .F, et al., A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma. Hepatology., 2013, 57(1), 195-204.10.1002/hep.25994Search in Google Scholar PubMed

[7] Petrelli A., Perra A., Cora D., Sulas P., Menegon S., Manca C., et al., MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC), Hepatology., 2014, 59(1), 228-41.10.1002/hep.26616Search in Google Scholar PubMed

[8] Yi M., Li M., Long X., Ye J., Cui J., Wei W., et al., miR-520e regulates cell proliferation, apoptosis and migration in breast cancer, Oncol Lett., 2016, 12(5), 3543-3548.10.3892/ol.2016.5085Search in Google Scholar PubMed PubMed Central

[9] Brueckner B., Stresemann C., Kuner R., Mund C., Musch T., Meister M., et al., The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function, Cancer Res., 2007, 67(4), 1419-1423.10.1158/0008-5472.CAN-06-4074Search in Google Scholar PubMed

[10] He F.C., Meng W.W., Qu Y.H., Zhou M.X., He J., Lv P., et al., Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma, World J Gastroenterol., 2015, 21(15), 4660-4665.10.3748/wjg.v21.i15.4660Search in Google Scholar PubMed PubMed Central

[11] Liu F., Liu S., Ai F., Zhang D., Xiao Z., Nie X., et al., miR-107 promotes proliferation and inhibits apoptosis of colon cancer cells by targeting prostate apoptosis responde-4 (PAR4), Oncol Res., 2016 Nov 29. 10.3727/096504016X14803476672380 [Epub ahead of print].Search in Google Scholar

[12] Loginov V.I., Burdennyy A.M., Pronina I.V., Khokonova V.V., Kurevljov S.V., Kazubskaya T.P., et al., [Novel miRNA genes hypermethylated in breast cancer], Mol Biol (Mosk)., 2016, 50(5), 797-802.10.1134/S0026893316050101Search in Google Scholar

[13] Wang S., Ma G., Zhu H., Lv C., Chu H., Tong N., et al., miR-107 regulates tumor progression by targeting NF1 in gastric cancer, Sci Rep., 2016, 6, 36531.10.1038/srep36531Search in Google Scholar

[14] Gao B., Hao S., Tian W., Jiang Y., Zhang M., Guo L., et al., MicroRNA-107 is downregulated and having tumor suppressive effect in breast cancer by negatively regulating BDNF, J Gene Med., 2016 Nov 3. 10.1002/jgm.2932 [Epub ahead of print].Search in Google Scholar

[15] Wang Y., Chen F., Zhao M., Yang Z., Zhang S., Ye L., et al., MiR-107 suppresses proliferation of hepatoma cells through targeting HMGA2 mRNA 3’UTR, Biochem Biophys Res Commun., 2016, 480(3), 455-460.10.1016/j.bbrc.2016.10.070Search in Google Scholar

[16] Zhong Z., Lv M., Chen J., Screening differential circular RNA expression profiles reveals the regulatory role of circTCF25- miR-103a-3p/miR-107-CDK6 pathway in bladder carcinoma, Sci Rep., 2016, 6, 30919.10.1038/srep30919Search in Google Scholar

[17] Datta J., Islam M., Dutta S., Roy S., Pan Q., Teknos T.N., Suberoylanilide hydroxamic acid inhibits growth of head and neck cancer cell lines by reactivation of tumor suppressor microRNAs, Oral Oncol., 2016, 56, 32-9.10.1016/j.oraloncology.2016.02.015Search in Google Scholar

[18] Takahashi Y., Forrest A.R., Maeno E., Hashimoto T., Daub C.O., Yasuda J., MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines, PLoS One., 2009, 4(8), e6677.10.1371/journal.pone.0006677Search in Google Scholar

[19] Zhong K.Z., Chen W.W., Hu X.Y., Jiang A.L., Zhao J., Clinicopathological and prognostic significance of microRNA-107 in human non small cell lung cancer, Int J Clin Exp Pathol., 2014, 7(7), 4545-4551.Search in Google Scholar

[20] Tan C.S., Gilligan D., Pacey S., Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer, Lancet Oncol., 2015, 16(9), e447-459.10.1016/S1470-2045(15)00246-6Search in Google Scholar

[21] Zhang Z., Zhang L., Yin Z.Y., Fan X.L., Hu B., Wang L.Q., et al., miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8, Int J Clin Exp Pathol., 2014, 7(10), 7236-7241.Search in Google Scholar

[22] Cui J., Mo J., Luo M., Yu Q., Zhou S., Li T., et al., c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer, Int J Clin Exp Pathol., 2015, 8(10), 12400-12409.Search in Google Scholar

[23] Xia H., Li Y., Lv X., MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer, Int J Oncol., 2016, 49(4), 1325-333.10.3892/ijo.2016.3628Search in Google Scholar PubMed PubMed Central

[24] Park W.R., Nakamura Y., p53CSV, a novel p53-inducible gene involved in the p53-dependent cell-survival pathway, Cancer Res., 2005, 65(4), 1197-1206.10.1158/0008-5472.CAN-04-3339Search in Google Scholar PubMed

[25] Felix R.S., Colleoni G.W., Caballero O.L., Yamamoto M., Almeida M.S., Andrade V.C., et al., SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis, Cancer Lett., 2009, 278(1), 41-48.10.1016/j.canlet.2008.12.022Search in Google Scholar PubMed

[26] Fook-Alves V.L., de Oliveira M.B., Zanatta D.B., Strauss B.E., Colleoni G.W., TP53 Regulated Inhibitor of Apoptosis 1 (TRIAP1) stable silencing increases late apoptosis by upregulation of caspase 9 and APAF1 in RPMI8226 multiple myeloma cell line, Biochim Biophys Acta., 2016, 1862(6), 1105-1110.10.1016/j.bbadis.2016.03.011Search in Google Scholar PubMed

[27] Andrysik Z., Kim J., Tan A.C., Espinosa J.M., A genetic screen identifies TCF3/E2A and TRIAP1 as pathway-specific regulators of the cellular response to p53 activation, Cell Rep., 2013, 3(5), 1346-135410.1016/j.celrep.2013.04.014Search in Google Scholar PubMed PubMed Central

[28] Siu M.K., Abou-Kheir W., Yin J.J., Chang Y.S., Barrett B., Suau F., et al., Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance, 2014, 5(11), 3770-3784.10.18632/oncotarget.1994Search in Google Scholar PubMed PubMed Central

[29] Adams C., Cazzanelli G., Rasul S., Hitchinson B., Hu Y., Coombes R.C., et al., Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance. Oncol Rep., 2015, 34(1), 415-422.10.3892/or.2015.3988Search in Google Scholar PubMed

[30] Li Y., Tang X., He Q., Yang X., Ren X., Wen X., et al., Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma, PLoS Genet., 2016, 12(7), e1006183.10.1371/journal.pgen.1006183Search in Google Scholar PubMed PubMed Central

Received: 2017-4-10
Accepted: 2017-4-29
Published Online: 2017-7-6

© 2017 Bing Wang et al.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Research Articles
  2. Field Performance and Genetic Fidelity of Micropropagated Plants of Coffea canephora (Pierre ex A. Froehner)
  3. Research Articles
  4. Foliage maturity of Quercus ilex affects the larval development of a Croatian coastal population of Lymantria dispar (Lepidoptera: Erebidae)
  5. Research Articles
  6. Structural and functional impact of SNPs in P-selectin gene: A comprehensive in silico analysis
  7. Research Articles
  8. High embryogenic ability and regeneration from floral axis of Amorphophallus konjac (Araceae)
  9. Research Articles
  10. Terpene content of wine from the aromatic grape variety ‘Irsai Oliver’ (Vitis vinifera L.) depends on maceration time
  11. Research Articles
  12. Light and smell stimulus protocol reduced negative frontal EEG asymmetry and improved mood
  13. Research Articles
  14. Swailing affects seed germination of plants of European bio-and agricenosis in a different way
  15. Research Articles
  16. Survey analysis of soil physicochemical factors that influence the distribution of Cordyceps in the Xiahe Region of Gansu Province
  17. Research Articles
  18. Production of biogas: relationship between methanogenic and sulfate-reducing microorganisms
  19. Research Articles
  20. Pentraxin 3 and atherosclerosis among type 2 diabetic patients
  21. Research Articles
  22. Evaluation of ribosomal P0 peptide as a vaccine candidate against Argulus siamensis in Labeo rohita
  23. Research Articles
  24. Variation of autosomes and X chromosome STR in breast cancer and gynecological cancer tissues
  25. Research Articles
  26. Response of antioxidant enzymes to cadmium-induced cytotoxicity in rat cerebellar granule neurons
  27. Research Articles
  28. Cardiac hypertrophy and IGF-1 response to testosterone propionate treatment in trained male rats
  29. Research Articles
  30. BRAF-activated non-protein coding RNA (BANCR) advances the development of esophageal squamous cell carcinoma via cell cycle
  31. Research Articles
  32. The influence of soil salinity on volatile organic compounds emission and photosynthetic parameters of Solanum lycopersicum L. varieties
  33. Research Articles
  34. Simple Protocol for immunoglobulin G Purification from Camel “Camelus dromedarius” Serum
  35. Research Articles
  36. Expression of psbA1 gene in Synechocystis sp. PCC 6803 is influenced by CO2
  37. Research Articles
  38. Frequency of Thrombophilic Gene Mutations in Patients with Deep Vein Thrombosis and in Women with Recurrent Pregnancy Loss
  39. Research Articles
  40. Evaluation of anticancer properties of a new α-methylene-δ-lactone DL-249 on two cancer cell lines
  41. Research Articles
  42. Impact of heated waters on water quality and macroinvertebrate community in the Narew River (Poland)
  43. Research Articles
  44. Effects of Some Additives on In Vitro True Digestibility of Wheat and Soybean Straw Pellets
  45. Research Articles
  46. RNAi-mediated gene silencing in Rhynchophorus ferrugineus (Oliver) (Coleoptera: Curculionidae)
  47. Research Articles
  48. New pathway of icariin-induced MSC osteogenesis: transcriptional activation of TAZ/Runx2 by PI3K/Akt
  49. Research Articles
  50. Tudor-SN protein expression in colorectal cancer and its association with clinical characteristics
  51. Research Articles
  52. Proteomic and bioinformatics analysis of human saliva for the dental-risk assessment
  53. Research Articles
  54. Reverse transcriptase sequences from mulberry LTR retrotransposons: characterization analysis
  55. Research Articles
  56. Strain Stimulations with Different Intensities on Fibroblast Viability and Protein Expression
  57. Research Articles
  58. miR-539 mediates osteoblast mineralization by regulating Distal-less genes 2 in MC3T3-E1 cell line
  59. Research Articles
  60. Diversity of Intestinal Microbiota in Coilia ectenes from Lake Taihu, China
  61. Research Articles
  62. The production of arabitol by a novel plant yeast isolate Candida parapsilosis 27RL-4
  63. Research Articles
  64. Effectiveness of Azospirillum brasilense Sp245 on young plants of Vitis vinifera L.
  65. Research Articles
  66. Changes of photochemical efficiency and epidermal polyphenols content of Prosopis glandulosa and Prosopis juliflora leaves exposed to cadmium and copper
  67. Research Articles
  68. Ultraweak photon emission in strawberry fruit during ripening and aging is related to energy level
  69. Research Articles
  70. Molecular cloning, characterization and evolutionary analysis of leptin gene in Chinese giant salamander, Andrias davidianus
  71. Research Articles
  72. Longevity and stress resistance are affected by activation of TOR/Myc in progenitor cells of Drosophila gut
  73. Research Articles
  74. Curcumin attenuates oxidative stress in liver in Type 1 diabetic rats
  75. Research Articles
  76. Risk factors of long-term postoperative renal function after partial nephrectomy in a solitary kidney
  77. Research Articles
  78. Developmental anomalies of the right hepatic lobe: systematic comparative analysis of radiological features
  79. Review articles
  80. Genetic Defects Underlie the Non-syndromic Autosomal Recessive Intellectual Disability (NS-ARID)
  81. Review articles
  82. Research Progress on Tissue Culture and Genetic Transformation of Kenaf (Hibiscus cannabinus)
  83. Topical Issue On Precision Medicine
  84. MiR-107 inhibits proliferation of lung cancer cells through regulating TP53 regulated inhibitor of apoptosis 1 (TRIAP1)
  85. Topical Issue On Precision Medicine
  86. The functional role of exosome microRNAs in lung cancer
  87. Topical Issue On Precision Medicine
  88. The diagnostic value of serum microRNA-183 and TK1 as biomarkers for colorectal cancer diagnosis
  89. Topical Issue On Precision Medicine
  90. Screening feature modules and pathways in glioma using EgoNet
  91. Topical Issue On Precision Medicine
  92. Isoliquiritigenin inhibits colorectal cancer cells HCT-116 growth by suppressing the PI3K/AKT pathway
  93. Topical Issue On Precision Medicine
  94. Association between Caveolin-1 expression and pathophysiological progression of femoral nerves in diabetic foot amputation patients
  95. Topical Issue On Precision Medicine
  96. Biomarkers in patients with myocardial fibrosis
  97. Topical Issue On Precision Medicine
  98. Dysregulated pathways for off-pump coronary artery bypass grafting
  99. Topical Issue On Precision Medicine
  100. Individualized identification of disturbed pathways in sickle cell disease
  101. Topical Issue On Precision Medicine
  102. The prognostic value of serum PCT, hs-CRP, and IL-6 in patients with sepsis
  103. Topical Issue On Precision Medicine
  104. Sevoflurane-medicated the pathway of chemokine receptors bind chemokines in patients undergoing CABG
  105. Topical Issue On Precision Medicine
  106. The functional role of microRNAs in laryngeal carcinoma
  107. Topical Issue On Precision Medicine
  108. Revealing pathway cross-talk related to diabetes mellitus by Monte Carlo Cross-Validation analysis
  109. Topical Issue On Precision Medicine
  110. Correlation between CDKAL1 rs10946398C>A single nucleotide polymorphism and type 2 diabetes mellitus susceptibility: A meta-analysis
  111. Special Issue on Agricultural and Biological Sciences
  112. Effects of environmental variables on seedling distribution of rare and endangered Dacrydium pierrei
  113. Special Issue on Agricultural and Biological Sciences
  114. Study on synthesis and properties of nanoparticles loaded with amaryllidaceous alkaloids
  115. Special Issue on Agricultural and Biological Sciences
  116. Bacterial Infection Potato Tuber Soft Rot Disease Detection Based on Electronic Nose
  117. Special Issue on Agricultural and Biological Sciences
  118. Effects of subsoiling on maize yield and water-use efficiency in a semiarid area
Downloaded on 28.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/biol-2017-0023/html
Scroll to top button